一个STAT1-GBP1轴通过抑制CDKI表达来调节产后乳腺组织中的上皮细胞增殖
Joshua W Ogony1, Laura M Pacheco-Spann2, Amanda Arnold3
1Department of Cancer Biology, Mayo Clinic, 4500 San Pablo Road S, Jacksonville, FL, 32224, USA.
Breast cancer research : BCR
|September 26, 2025
概括
一种产后干扰素特征,涉及信号转换器和转录1 (STAT1) 和酸结合蛋白1 (GBP1) 的激活剂,通过抑制细胞循环抑制剂,促进乳腺细胞的增殖. 这可能解释产后乳腺癌风险的增加.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 产后乳腺癌的死亡率高于无产妇女性.
- 产后乳腺癌的分子驱动因素仍然不清楚.
- 通过CDKI抑制研究了STAT1和GBP1在产后上皮细胞增殖中的作用.
研究的目的:
- 研究STAT1和GBP1在产后乳腺上皮细胞增殖中的作用.
- 为了确定STAT1和GBP1是否抑制循环林依赖性激酶抑制剂 (CDKI).
主要方法:
- 使用转录基因分析对产后和无卵性良性乳腺组织进行比较.
- 通过免疫组织化学检查了STAT1,GBP1和Ki67蛋白质的表达.
- 在人类乳腺上皮细胞 (HMECs) 中利用siRNA和lentiviral knockdown来评估CDKI表达,细胞周期和增殖.
主要成果:
- 产后组织显示了干扰素特征 (STAT1,GBP1),Ki67升高,CDKI降低.
- 在HMEC中,STAT1/GBP1 knockdown增加了p21/p57,诱导了G1停止,并减少了扩散.
- 英1调解STAT1-Ki67链接;STAT1和英1合作抑制核扩散.
结论:
- 确定了一个STAT1-GBP1轴,通过抑制CDKI来增强产后上皮细胞增殖.
- 这种机制可能解释产后乳腺癌易受伤害率的增加.
- 突出了产后乳腺组织的潜在生物标志物和早期干预目标.
相关概念视频
02:34Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
01:23Negative Regulator Molecules
38.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.3K
02:39Positive Regulator Molecules
6.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.5K
01:16TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
02:38Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
02:17Separation of Sister Chromatids
4.4K
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
At the onset of anaphase, separase, a proteolytic enzyme, is...
4.4K